Pfizer-BioNTech COVID-19 Vaccine Safe for Children Ages 5-17

JAMA Network

About The Study: Among 20 health outcomes that were monitored in near real time in this study including more than 3 million children ages 5 to 17 who received the Pfizer-BioNTech COVID-19 vaccine, a safety signal was identified for only myocarditis or pericarditis. Consistent with other published reports, these results provide additional evidence that COVID-19 vaccines are safe in children.

Authors: Steven A. Anderson, Ph.D., M.P.P., of the Food and Drug Administration in Silver Spring, Maryland, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamapediatrics.2023.1440)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.